- Outcomes of Palivizumab Prophylaxis for Respiratory Syncytial Virus Infection in Preterm Children with Bronchopulmonary Dysplasia at a Single Hospital in Korea from 2005 to 2009
-
Chang SG, Park MS, Yu JE
- KMID: 1779256
- J Korean Med Sci.
- 2010 Feb;25(2):251-256.
- doi: 10.3346/jkms.2010.25.2.251
This study was performed to evaluate the utilization and outcomes of palivizumab in high risk children born prematurely with chronic lung disease (CLD). A retrospective review of 128 patients was... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia
-
Han YM, Seo HJ, Choi SH, Jung YJ, Ahn SY, Yoo HS, Sung SI, Shim JW, Lee YK, Ko SY, Shin SM, Hwang JH, Lee JH, Choi BM, Kim ES, Jeon JH, Kim SS, Chang YS, Park WS
- KMID: 2164478
- J Korean Med Sci.
- 2015 Jul;30(7):924-931.
- doi: 10.3346/jkms.2015.30.7.924
The aim of this study was to observe the effects of prophylactic palivizumab on hospitalization secondary to respiratory syncytial virus (RSV) infection (RSVhospitalization) in former very low birth weight infants... -
- CITED
-
- Close
- SHARE
-
- Close
